BIOEF - H. Univ. Donostia/BIODONOSTIA

Predictor of PML

Biomarkers
Autoimmune & Inflammation
Central Nervous System
Predictor of the risk of developing progressive multifocal leucoencephalopathy in natalizumab-treated multiple sclerosis patients
2Preclinical Validation, 1R+D